Cencora Inc., a Conshohocken-based wholesale drug distributor, scrubbed a diversity, equity, and inclusion page from its ...

Reconciliations of these measures to GAAP are provided in today’s press release, which is available on our website at investor.cencora.com. We’ve also posted a slide presentation to accompany ...

A slide presentation for investors has also been posted on the Company’s website at investor.cencora.com. Participating in the conference call will be: Robert P. Mauch, President & Chief ...

S hares of Cencora (COR) have been strong performers lately, with the stock up 13.4% over the past month. The stock hit a new 52-week high of $256.81 in the previous session.

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

A slide presentation for investors has also been posted on the Company’s website at investor.cencora.com. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive ...

Mauch emphasized the strategic alignment of the RCA acquisition with Cencora’s pharmaceutical-centric strategy. CFO James Cleary noted, "Cencora delivered strong results in the first quarter ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...